Lichen International Limited
LICN · NASDAQ
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $14 | $23 | $18 | $24 |
| % Growth | -39% | 29.2% | -24.1% | – |
| Cost of Goods Sold | $8 | $9 | $7 | $9 |
| Gross Profit | $7 | $15 | $11 | $14 |
| % Margin | 46.2% | 62.9% | 60.6% | 60.8% |
| R&D Expenses | $0 | $1 | $0 | $1 |
| G&A Expenses | $6 | $12 | $5 | $4 |
| SG&A Expenses | $12 | $21 | $9 | $5 |
| Sales & Mktg Exp. | $6 | $9 | $4 | $1 |
| Other Operating Expenses | $0 | -$1 | $0 | -$1 |
| Operating Expenses | $12 | $21 | $9 | $5 |
| Operating Income | -$5 | -$6 | $2 | $9 |
| % Margin | -36.8% | -26.7% | 9.4% | 39.5% |
| Other Income/Exp. Net | -$4 | $0 | $0 | $0 |
| Pre-Tax Income | -$9 | -$6 | $2 | $9 |
| Tax Expense | $0 | $1 | $1 | $2 |
| Net Income | -$9 | -$7 | $1 | $7 |
| % Margin | -65.6% | -29.5% | 4.2% | 29.3% |
| EPS | -33.08 | -0.46 | 0.052 | 0.26 |
| % Growth | -7,091.3% | -991.5% | -80.2% | – |
| EPS Diluted | -33.08 | -0.46 | 0.052 | 0.26 |
| Weighted Avg Shares Out | 0 | 15 | 15 | 27 |
| Weighted Avg Shares Out Dil | 0 | 15 | 15 | 27 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $2 | $2 | $0 | $0 |
| EBITDA | -$3 | -$4 | $2 | $10 |
| % Margin | -23.2% | -16.1% | 11.6% | 40.5% |